Kawasaki, Japan

Erika Watanabe

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Ajinomoto Co., Ltd.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erika Watanabe. Retrieved from https://idiyas.com/inventor/erika-watanabe-hd7oh5sf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Erika Watanabe

Introduction

Erika Watanabe is a notable inventor based in Kawasaki, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of novel methods for producing important compounds.

Latest Patents

Watanabe holds a patent for a mutant glutathione synthetase and a method for producing gamma-glutamyl-valyl-glycine. This invention involves a mutant glutathione synthetase (GSHB) that is specifically designed to generate γ-Glu-Val-Gly. The production method utilizes a mutant GSHB with mutations at various positions, including V7, N13, I14, N15, K17, F22, F95, M165, N199, Y200, P202, I274, T285, and P287.

Career Highlights

Watanabe's work at Ajinomoto Co., Ltd. has been instrumental in advancing biotechnological applications. Her research focuses on enhancing the efficiency of biochemical processes, which has implications for various industries, including pharmaceuticals and food production.

Collaborations

Some of her coworkers include Ayako Sato and Eri Higashiura, who contribute to her innovative projects and research initiatives.

Conclusion

Erika Watanabe's contributions to the field of biochemistry through her patent and work at Ajinomoto Co., Ltd. highlight her role as a leading inventor in her domain. Her innovative approaches continue to pave the way for advancements in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…